Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma

Cancer

Volumn 98, Issue 7, 2003, Pages 1438-1443

  Boonla, Chanchai ^a,b   Wongkham, Sopit ^a,b   Sheehan, John Kieran ^c   Wongkham, Chaisiri ^a,b   Bhudhisawasdi, Vajarabhongsa ^a,b   Tepsiri, Nisana ^a,b   Pairojkul, Chawalit ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bile duct; Blood group; Cholangiocarcinoma; MUC5AC; Mucin; Neoplasm; Prognosis; Serum; Survival; Tumor marker

Indexed keywords

MUCIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD GROUP A; CANCER SURVIVAL; FEMALE; GENE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUC5AC GENE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

ADULT; AGED; ANALYSIS OF VARIANCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINS; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0141675097     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11652     Document Type: Article

References (28)

1. Suzuki M, Takahashi T, Ouchi K, Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989;64:658-666.
2. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75:171-190.
3. Reed DN Jr., Vitale GC, Martin R, et al. Bile duct carcinoma: trends in treatment in the nineties. Am Surg. 2000;66:711-714; discussion, 714-715.
4. Kim YS, Gum J Jr., Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J. 1996;13:693-707.
5. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res. 1999;59:4083-4089.
6. Gum JR Jr., Crawley SC, Hicks JW, Szymkowski DE, Kim YS. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun. 2002;291:466-475.
7. Pallesen LT, Berglund L, Rasmussen LK, Petersen TE, Rasmussen JT. Isolation and characterization of MUC15, a novel cell membrane-associated mucin. Eur J Biochem. 2002;269:2755-2763.
8. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem. 2001;276:18327-18336.
9. Gum JR Jr. Human mucin glycoproteins: varied structures predict diverse properties and specific functions. Biochem Soc Trans. 1995;23:795-799.
10. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993;53:641-651.
11. Taylor-Papadimitriou J, Epenetos AA. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol. 1994;12:227-233.
12. Kitamura H, Yonezawa S, Tanaka S, Kim YS, Sato E. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Jpn J Cancer Res. 1996;87:631-640.
13. Bhavanandan VP. Cancer-associated mucins and mucin-type glycoproteins. Glycobiology. 1991;1:493-503.
14. Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology. 1996;24:1074-1078.
15. Vandenhaute B, Buisine MP, Debailleul V, et al. Mucin gene expression in biliary epithelial cells. J Hepatol. 1997;27:1057-1066.
16. Sasaki M, Nakanuma Y, Terada T, Kim YS. Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. Am J Pathol. 1995;147:574-579.
17. Sasaki M, Nakanuma Y. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases. Hepatology. 1996;24:539-543.
18. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology. 1998;27:54-61.
19. Wongkham S, Sheehan JK, Boonla C, et al. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Cancer Lett. 2003;195:93-99.
20. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 5th edition. New York: John Wiley & Sons, 1997.
21. Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK. Respiratory mucins: identification of core proteins and glycoforms. Biochem J. 1996;316:967-975.
22. Sheehan JK, Brazeau C, Kutay S, et al. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem J. 2000;347:37-44.
23. Watkins WM. Genetic regulation of the structure of blood-group-specific glycoproteins. Biochem Soc Symp. 1974;40:125-146.
24. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int. 1997;47:813-830.
25. Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer. 2002;94:1770-1776.
26. Higashi M, Yonezawa S, Ho JJ, et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology. 1999;30:1347-1355.
27. Yonezawa S, Sueyoshi K, Nomoto M, et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol. 1997;28:344-352.
28. Yonezawa S, Horinouchi M, Osako M, et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol Int. 1999;49:45-54.